ENTITY

Biomarin Pharmaceutical (BMRN US)

60
Analysis
Health CareUnited States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
Company Event21 Feb 2025 05:30 • Upcoming
Add To Calendar
Company Event30 Oct 2024 04:30 • Latest
Company Event04 Sep 2024 22:30
Company Event06 Aug 2024 04:30
Company Event25 Apr 2024 04:30
x